The document outlines a proposal for establishing a world-leading Alzheimer Center at Karolinska Institutet in Stockholm, Sweden. It discusses the current state of Alzheimer research at the institute, the need for a unified center, and the financial requirements for such an initiative. The proposal emphasizes the importance of translational research, combining basic and clinical research to understand the molecular, cellular, and genetic mechanisms of Alzheimer disease. It also highlights the potential benefits for patients and the Swedish drug industry.
documents/EFTA00283681.pdf
{}